NRG Therapeutics
  • Home
  • About
    • Overview
    • Team
    • Investors
  • Science
    • Overview
    • ALS
    • Parkinson’s
  • Pipeline
  • Partners
  • News & Events
    • Press Releases
    • In The News
    • Events
  • Contact
  • Menu Menu

News

Parkinson’s UK invests a further £490k in NRG Therapeutics to Progress Parkinson’s Drug Discovery Programme

NRG Therapeutics Ltd (“NRG” or “company”), an innovative…
23 August 2021/by Webadm

NRG Therapeutics Awarded $500K Grant from The Michael J. Fox Foundation to Progress Parkinson’s Programme

NRG Therapeutics Ltd (“NRG” or “company”), an innovative…
29 July 2021/by Webadm

Parkinson’s UK continues drug discovery with NRG Therapeutics Ltd

Parkinson's UK has invested an additional £1 million in NRG…
7 August 2020/by Webadm

Dr Richard Seabrook joins Board of NRG Therapeutics

Richard brings over 25 years of experience in scientific translation…
5 November 2019/by Webadm

Charity invests £1 million to develop a treatment to slow down progression of Parkinson’s

Charity Parkinson’s UK is partnering with NRG Therapeutics…
1 July 2019/by Webadm
Page 3 of 3123

© NRG Therapeutics

linkedin
  • Terms & Conditions
  • Privacy Policy
Scroll to top Scroll to top Scroll to top